Market Overview:
Physostigmine is a cholinergic agent, which is used to treat myasthenia gravis and reversal of the effects of anticholinergic drugs. It is also used for the diagnosis of glaucoma. Physostigmine exists as two enantiomers, (R)-(+)-physostigmine and (S)-(-)-physostigmine. The racemic mixture physostigmine has poor pharmacokinetic properties due to high inter-individual variability in its absorption, distribution, metabolism and excretion.
Product Definition:
Physostigmine is a cholinergic drug that is used to treat myasthenia gravis and to reverse the effects of anticholinergic drugs.
Intravenous:
Intravenous (IV) drug delivery is a mode of drug delivery, which involves injecting the drugs into the blood vessels of the body. The IV mode of drug delivery is most commonly used for injectable drugs. Intravenous injection can be done by two routes; peripheral and central venous. Peripheral route involves veins located on the outer part of the arms or legs, which are more convenient and common way to deliver an IV dose.
Intramuscular:
Intramuscular is a drug that is administered to the muscle. It works by stimulating certain chemicals in the brain which causes drowsiness and relaxation of muscles. Intramuscularly refers to injecting drugs into muscle tissues or directly into muscles themselves. Intra muscular can also be used as an adjective referrring to injections made into the muscle itself rather than just intramuscular injections of drugs (intra-muscular injection).
Application Insights:
The drug store application segment accounted for the largest revenue share in 2017. The major factor contributing to this growth is that physostigmine is used as a standard treatment for Parkinson¢â‚¬â„¢s disease, thus, increasing its use in drug stores as an over-the-counter medicine. Drug stores are available in different forms and doses which may vary from one another; these factors are likely to increase product demand at retail pharmacies.
The hospital application segment is expected to witness the fastest growth rate during the forecast period owing to increased research on new therapeutic applications of physostigmine such as Alzheimer¢â‚¬â„¢s disease and other neurological disorders.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high patient awareness. The region is expected to maintain its dominance over the forecast period due to factors such as increasing geriatric population, rising healthcare expenditure, and technological advancements. Moreover, growing demand for new product development is also expected to drive growth during the same period.
Asia Pacific is anticipated to be one of fastest-growing regions during the forecast years on account of rapid economic development coupled with increasing disposable income levels in emerging countries such as China and India. Furthermore, government initiatives encouraging R&D activities are further anticipated boost growth prospects in this region over next eight years. Increasing prevalence of chronic disorders coupled with rising healthcare expenditure by consumers will also support regional market expansion over coming years (USD X billion).
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 5.0% from 2016 to 2020, reaching nearly 1.5 billion by 2020. This growing population is susceptible to age-related disorders such as Alzheimer’s disease, which will drive the demand for physostigmine and related products over the forecast period.
- Rising prevalence of neurological disorders: The global prevalence of neurological disorders is estimated to be around 615 million in 2015 and is expected to grow at a CAGR of 6.5% from 2016 to 2020, reaching 886 million by 2020. This high prevalence will lead to an increase in the demand for physostigmine and related products over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Physostigmine Market Research Report
By Type
Intravenous, Intramuscular, Ophthalmic
By Application
Hospital, Drug Store
By Companies
Alcon, Akorn, IFET, Merck, Hangzhou APIChem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Physostigmine Market Report Segments:
The global Physostigmine market is segmented on the basis of:
Types
Intravenous, Intramuscular, Ophthalmic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alcon
- Akorn
- IFET
- Merck
- Hangzhou APIChem
Highlights of The Physostigmine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intravenous
- Intramuscular
- Ophthalmic
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Physostigmine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Physostigmine is a medication used to treat nerve gas poisoning. It works by blocking the action of acetylcholine, a neurotransmitter that helps nerves communicate.
Some of the key players operating in the physostigmine market are Alcon, Akorn, IFET, Merck, Hangzhou APIChem.
The physostigmine market is expected to grow at a compound annual growth rate of 5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Physostigmine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Physostigmine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Physostigmine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Physostigmine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Physostigmine Market Size & Forecast, 2018-2028
4.5.1 Physostigmine Market Size and Y-o-Y Growth
4.5.2 Physostigmine Market Absolute $ Opportunity
Chapter 5 Global Physostigmine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Physostigmine Market Size Forecast by Type
5.2.1 Intravenous
5.2.2 Intramuscular
5.2.3 Ophthalmic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Physostigmine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Physostigmine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Physostigmine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Physostigmine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Physostigmine Analysis and Forecast
9.1 Introduction
9.2 North America Physostigmine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Physostigmine Market Size Forecast by Type
9.6.1 Intravenous
9.6.2 Intramuscular
9.6.3 Ophthalmic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Physostigmine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Physostigmine Analysis and Forecast
10.1 Introduction
10.2 Europe Physostigmine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Physostigmine Market Size Forecast by Type
10.6.1 Intravenous
10.6.2 Intramuscular
10.6.3 Ophthalmic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Physostigmine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Physostigmine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Physostigmine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Physostigmine Market Size Forecast by Type
11.6.1 Intravenous
11.6.2 Intramuscular
11.6.3 Ophthalmic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Physostigmine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Physostigmine Analysis and Forecast
12.1 Introduction
12.2 Latin America Physostigmine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Physostigmine Market Size Forecast by Type
12.6.1 Intravenous
12.6.2 Intramuscular
12.6.3 Ophthalmic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Physostigmine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Physostigmine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Physostigmine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Physostigmine Market Size Forecast by Type
13.6.1 Intravenous
13.6.2 Intramuscular
13.6.3 Ophthalmic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Physostigmine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Physostigmine Market: Competitive Dashboard
14.2 Global Physostigmine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alcon
14.3.2 Akorn
14.3.3 IFET
14.3.4 Merck
14.3.5 Hangzhou APIChem
